Ò. Serra

First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

Jaime Feliú, Antonieta Salud, María José Safont et al. · British Journal of Cancer · 2014 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

Almudena Cotes Sanchís, Javier Gállego, Raquel Hernández et al. · PLoS ONE · 2020 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

Antonio Irigoyen López, Javier Gállego, Carmen Guillén‐Ponce et al. · European Journal of Cancer · 2017 · 16 citations

Medicine, Oncology, Pharmacology +14